FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and discloses a method for evaluating the effectiveness of treating dry eye syndrome in diabetic patients. Method involves investigating a lachrymal fluid and evaluating levels of a soluble form of the receptor for interleukin-6 (sIL-6R) and neutrophil elastase (NE) before and after treatment, and if the level of at least one of the values, i.e. sIL-6 by 60% and more and NE by 50% or more, is decreased, the treatment is considered to be effective.
EFFECT: invention enables higher accuracy of evaluating the effectiveness of treating dry eye syndrome in diabetic patients by detecting such objective markers of inflammatory reaction intensity, as oscillation of levels of soluble form of receptor to interleukin-6 (sIL-6R) and neutrophil elastase (NE) before and after therapy.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DRY EYE SYNDROME TREATMENT IN PATIENTS WITH DIABETES MELLITUS | 2020 |
|
RU2749984C1 |
| METHOD OF TREATING DRY EYE SYNDROME | 2015 |
|
RU2581495C1 |
| DIAGNOSTIC TECHNIQUE AND METHOD OF THERAPY OF DRUG-INDUCED DRY EYE SYNDROME | 2014 |
|
RU2554818C1 |
| METHOD OF TREATING INFLAMMATORY EXUDATIVE POSTOPERATIVE REACTIONS FOLLOWING IMPLANTATION OF INTRAOCULAR LENS | 2008 |
|
RU2381775C1 |
| DIAGNOSTIC TECHNIQUE FOR DRY EYE SYNDROME | 2018 |
|
RU2702131C1 |
| METHOD FOR TREATMENT OF OPHTHALMIC AUTOIMMUNE DISEASE | 2005 |
|
RU2299750C1 |
| COMPOSITION AND METHOD FOR TREATMENT OF EYE DISEASE ASSICIATED WITH NUCLEIC ACIDS | 2012 |
|
RU2642609C2 |
| METHOD FOR PREDICTING THE RISK OF PROGRESSION OF DIABETIC RETINOPATHY IN PREGNANT WOMEN WITH DIABETES MELLITUS | 2023 |
|
RU2809639C1 |
| METHOD FOR DETECTING AN INFLAMMATORY COMPONENT THAT PROMOTES TUMOR GROWTH IN INITIAL CHOROIDAL MELANOMA | 2020 |
|
RU2748528C1 |
| METHOD FOR DETERMINING INDICATIONS FOR LASER COAGULATION REQUIRED BY MYOPIA IN PREGNANT WOMEN | 2013 |
|
RU2536827C1 |
